Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients
- PMID: 34554629
- PMCID: PMC8652758
- DOI: 10.1111/ajt.16853
Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients
Keywords: clinical research/practice; dialysis: hemodialysis; immunobiology; infectious disease; kidney transplantation/nephrology; translational research/science; vaccine.
Figures
References
-
- Stumpf J, Siepmann T, Lindner T, et al. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine [published online ahead of print July 23, 2021]. Lancet Reg Health Eur. 2021. doi: 10.1016/j.lanepe.2021.100178 - DOI - PMC - PubMed
-
- Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021;385(7):661–662. https://www.nejm.org/doi/full/10.1056/NEJMc2108861. - DOI - PMC - PubMed
-
- Crotty S. COVID-19 vaccine responses provide insights into how the immune system perceives threats. Science. 2021;372(6549):1392–1393.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
